Expectant Management or Early Ibuprofen for Patent Ductus Arteriosus. Reply

N Engl J Med. 2023 May 18;388(20):1917-1918. doi: 10.1056/NEJMc2304388.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Ductus Arteriosus, Patent* / drug therapy
  • Humans
  • Ibuprofen* / therapeutic use
  • Infant, Newborn
  • Infant, Premature
  • Watchful Waiting

Substances

  • Ibuprofen
  • Anti-Inflammatory Agents, Non-Steroidal